Efficacy of cabergoline therapy in patients with non-functioning pituitary adenomas: A single center clinical experience

Efficacy of cabergoline therapy in patients with non-functioning pituitary adenomas: A single center clinical experience

ABSTRACT Objective: To evaluate the response to cabergoline (CBG) treatment in patients with non-functioning pituitary adenomas (NFPA). Subjects and methods: Retrospective, single tertiary care center study. A total of 44 patients were treated with 3 mg/week of CBG, 32 after surgical treatment (tr...

Full description

Bibliographic Details
Main Authors: Guadalupe Vargas-Ortega, Baldomero González-Virla, Lourdes Balcázar-Hernández, Rocío Arreola-Rosales, Francisco Javier Benitez-Rodríguez, Blas López Félix, Moisés Mercado
Format: Article
Language:English
Published: Brazilian Society of Endocrinology and Metabolism 2022-07-01
Series:Archives of Endocrinology and Metabolism
Subjects:
Nonfunctioning pituitary adenomas
dopamine agonists
cabergoline
dopamine receptors
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972022005008207&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972022005008207&tlng=en

Similar Items